CA Stock MarketDetailed Quotes

IME Imagin Medical Inc

Watchlist
  • 0.015
  • 0.0000.00%
15min DelayMarket Closed Apr 11 09:30 ET
162.45KMarket Cap-187P/E (TTM)

Imagin Medical Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
(Q1)Dec 31, 2021
(FY)Sep 30, 2021
(Q4)Sep 30, 2021
(Q3)Jun 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-54.56%362.42K
-14.19%669.21K
-8.38%3.55M
-18.25%1.1M
-10.37%872.96K
-11.12%797.64K
18.41%779.89K
-11.52%3.87M
95.34%1.34M
67.69%973.95K
Selling and administrative expenses
-30.64%315.53K
-4.77%323.9K
-31.04%1.46M
-72.09%178.78K
0.79%481.2K
-17.22%454.95K
-23.12%340.14K
-4.93%2.11M
18.39%640.56K
11.77%477.44K
-General and administrative expense
-30.64%315.53K
-4.77%323.9K
-31.04%1.46M
-72.09%178.78K
0.79%481.2K
-17.22%454.95K
-23.12%340.14K
-4.93%2.11M
18.39%640.56K
11.77%477.44K
Research and development costs
-99.83%553
-30.81%298.99K
18.01%2.05M
28.69%895.57K
-21.48%384.11K
-1.58%335.04K
106.85%432.1K
-18.44%1.73M
427.07%695.9K
230.86%489.17K
Depreciation amortization depletion
505.62%46.33K
505.62%46.33K
60.38%47.13K
229.14%24.18K
4.12%7.65K
4.14%7.65K
4.12%7.65K
-8.67%29.39K
-50.54%7.35K
27.22%7.35K
-Depreciation and amortization
505.62%46.33K
505.62%46.33K
60.38%47.13K
229.14%24.18K
4.12%7.65K
4.14%7.65K
4.12%7.65K
-8.67%29.39K
-50.54%7.35K
27.22%7.35K
Operating profit
54.56%-362.42K
14.19%-669.21K
8.38%-3.55M
18.25%-1.1M
10.37%-872.96K
11.12%-797.64K
-18.41%-779.89K
11.52%-3.87M
-95.34%-1.34M
-67.69%-973.95K
Net non-operating interest income (expenses)
-39.28%-510.59K
-34.93%-2.28K
-13.06%-7.83K
-28.63%-2.19K
-50.41%-2.21K
-17,790.73%-366.58K
0.88%-1.69K
-225.34%-6.93K
-756.76%-1.7K
-313.33%-1.47K
Non-operating interest income
--0
----
----
----
----
--0
----
----
----
----
Non-operating interest expense
-17.18%1.44K
34.93%2.28K
13.06%7.83K
28.63%2.19K
50.41%2.21K
-15.08%1.74K
-0.88%1.69K
-12.48%6.93K
6.98%1.7K
-24.67%1.47K
Total other finance cost
39.55%509.14K
----
----
----
----
--364.84K
----
----
----
----
Other net income (expenses)
-101.69%-270
227.10%687.48K
114.02%1.06M
47.68%-3.57M
921.30%5.52M
101.13%15.94K
-651.39%-540.91K
-178,131.97%-7.59M
-488,998.57%-6.82M
20,168.08%540.63K
Gain on sale of security
-101.69%-270
127.19%1.4K
161.95%23.3K
-86.01%2.95K
144.67%9.56K
168.97%15.94K
63.65%-5.15K
-783.03%-37.62K
1,610.40%21.06K
-694.54%-21.41K
Special income (charges)
----
228.06%686.08K
113.78%1.04M
47.80%-3.57M
880.71%5.51M
----
-577.29%-535.76K
---7.56M
---6.84M
--562.04K
-Less:Other special charges
----
-228.06%-686.08K
-113.78%-1.04M
-47.80%3.57M
-880.71%-5.51M
----
577.29%535.76K
--7.56M
--6.84M
---562.04K
Income before tax
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.64%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
25.40%-434.79K
Income tax
Earnings from equity interest net of tax
Net income
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.64%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
25.40%-434.79K
Net income continuous operations
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.64%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
25.40%-434.79K
Noncontrolling interests
Net income attributable to the company
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.64%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
25.40%-434.79K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.64%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
25.40%-434.79K
Diluted earnings per share
33.33%-0.08
101.43%0.002
80.31%-0.25
47.78%-0.47
1,040.00%0.47
53.85%-0.12
-133.33%-0.14
-139.62%-1.27
-1,185.71%-0.9
28.57%-0.05
Basic earnings per share
33.33%-0.08
101.43%0.002
80.31%-0.25
47.78%-0.47
1,040.00%0.47
53.85%-0.12
-133.33%-0.14
-139.62%-1.27
-1,185.71%-0.9
28.57%-0.05
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022(Q1)Dec 31, 2021(FY)Sep 30, 2021(Q4)Sep 30, 2021(Q3)Jun 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -54.56%362.42K-14.19%669.21K-8.38%3.55M-18.25%1.1M-10.37%872.96K-11.12%797.64K18.41%779.89K-11.52%3.87M95.34%1.34M67.69%973.95K
Selling and administrative expenses -30.64%315.53K-4.77%323.9K-31.04%1.46M-72.09%178.78K0.79%481.2K-17.22%454.95K-23.12%340.14K-4.93%2.11M18.39%640.56K11.77%477.44K
-General and administrative expense -30.64%315.53K-4.77%323.9K-31.04%1.46M-72.09%178.78K0.79%481.2K-17.22%454.95K-23.12%340.14K-4.93%2.11M18.39%640.56K11.77%477.44K
Research and development costs -99.83%553-30.81%298.99K18.01%2.05M28.69%895.57K-21.48%384.11K-1.58%335.04K106.85%432.1K-18.44%1.73M427.07%695.9K230.86%489.17K
Depreciation amortization depletion 505.62%46.33K505.62%46.33K60.38%47.13K229.14%24.18K4.12%7.65K4.14%7.65K4.12%7.65K-8.67%29.39K-50.54%7.35K27.22%7.35K
-Depreciation and amortization 505.62%46.33K505.62%46.33K60.38%47.13K229.14%24.18K4.12%7.65K4.14%7.65K4.12%7.65K-8.67%29.39K-50.54%7.35K27.22%7.35K
Operating profit 54.56%-362.42K14.19%-669.21K8.38%-3.55M18.25%-1.1M10.37%-872.96K11.12%-797.64K-18.41%-779.89K11.52%-3.87M-95.34%-1.34M-67.69%-973.95K
Net non-operating interest income (expenses) -39.28%-510.59K-34.93%-2.28K-13.06%-7.83K-28.63%-2.19K-50.41%-2.21K-17,790.73%-366.58K0.88%-1.69K-225.34%-6.93K-756.76%-1.7K-313.33%-1.47K
Non-operating interest income --0------------------0----------------
Non-operating interest expense -17.18%1.44K34.93%2.28K13.06%7.83K28.63%2.19K50.41%2.21K-15.08%1.74K-0.88%1.69K-12.48%6.93K6.98%1.7K-24.67%1.47K
Total other finance cost 39.55%509.14K------------------364.84K----------------
Other net income (expenses) -101.69%-270227.10%687.48K114.02%1.06M47.68%-3.57M921.30%5.52M101.13%15.94K-651.39%-540.91K-178,131.97%-7.59M-488,998.57%-6.82M20,168.08%540.63K
Gain on sale of security -101.69%-270127.19%1.4K161.95%23.3K-86.01%2.95K144.67%9.56K168.97%15.94K63.65%-5.15K-783.03%-37.62K1,610.40%21.06K-694.54%-21.41K
Special income (charges) ----228.06%686.08K113.78%1.04M47.80%-3.57M880.71%5.51M-----577.29%-535.76K---7.56M---6.84M--562.04K
-Less:Other special charges -----228.06%-686.08K-113.78%-1.04M-47.80%3.57M-880.71%-5.51M----577.29%535.76K--7.56M--6.84M---562.04K
Income before tax 23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.64%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M25.40%-434.79K
Income tax
Earnings from equity interest net of tax
Net income 23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.64%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M25.40%-434.79K
Net income continuous operations 23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.64%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M25.40%-434.79K
Noncontrolling interests
Net income attributable to the company 23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.64%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M25.40%-434.79K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.64%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M25.40%-434.79K
Diluted earnings per share 33.33%-0.08101.43%0.00280.31%-0.2547.78%-0.471,040.00%0.4753.85%-0.12-133.33%-0.14-139.62%-1.27-1,185.71%-0.928.57%-0.05
Basic earnings per share 33.33%-0.08101.43%0.00280.31%-0.2547.78%-0.471,040.00%0.4753.85%-0.12-133.33%-0.14-139.62%-1.27-1,185.71%-0.928.57%-0.05
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data